Titre :
  • Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: Insights from BOLERO-2
Auteur : Rugo, Hope ; Pritchard, Kathleen ; Gnant, Michael ; Noguchi, Shinzaburo S. ; Piccart-Gebhart, Martine ; Hortobagyi, Gabriel N. ; Baselga, José ; Perez, Alejandra ; Geberth, Matthias M. ; Csöszi, Tibor T. ; Chouinard, Edmond E. ; Srimuninnimit, Vichien V. ; Puttawibul, Puttisak P. ; Eakle, Janice J. ; Feng, Wentao W. ; El-Hashimy, Mona M. ; Taran, Tetiana T. ; Bauly, Hounayda H. ; Burris, Howard H.A.
Informations sur la publication : Annals of oncology, 25, 4, mdu009, (page 808-815)
Statut de publication : Publié, 2014
Sujet CREF : Hématologie
Cancérologie
Mots-clés : Advanced breast cancer
Everolimus
Mammalian target of rapamycin (mTOR)
Safety
Mots-clés MeSH : Adult
Aged
Aged, 80 and over
Breast Neoplasms -- drug therapy -- genetics -- pathology
Disease-Free Survival
Drug-Related Side Effects and Adverse Reactions -- classification -- pathology
Female
Humans
Middle Aged
Neoplasm Staging
Postmenopause
Sirolimus -- administration & dosage -- adverse effects -- analogs & derivatives
TOR Serine-Threonine Kinases -- genetics
Note : SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:0923-7534 
info:doi/10.1093/annonc/mdu009
info:pii/mdu009
info:pmid/24615500